Long-term efficacy of AZAthioprine (aza) in inflammatory bowel disease (IBD) -: a European Multicenter study in 1200 patients with Crohn's disease (CD) and ulcerative colitis (UC)

被引：0

|

作者：

Holtmann, MH

Krummenauer, F

Claas, C

Kremeyer, K

Lorenz, D

Rainer, O

Vogel, I

Galle, PR

Boecker, U

Boehm, S

Büming, C

Duchmann, R

Gerken, G

Herfarth, H

Lingering, N

Kruis, W

Reinshagen, M

Schmidt, J

Stallmach, A

Stein, J

Sturm, A

Hommes, D

D'Haens, G

Rutgeerts, P

Neurath, M

机构：

来源：

GASTROENTEROLOGY | 2005年 / 128卷 / 04期

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

收藏

页码：A13 / A13

页数：1

相关论文

共 50 条

[1] Long-term effectiveness of azathioprine (AZA) for Crohn's disease (CD) and ulcerative colitis (UC)
Gisbert, Javier P.
Nino, R.
Cara, C.
Bourgois, M.
Rodrigo, L.
[J]. GASTROENTEROLOGY, 2007, 132 (04) : A517 - A517
[2] Drugs approved for therapy of inflammatory bowel disease (IBD); Crohn's disease (CD) versus ulcerative colitis (UC).
Prizont, R
McNeil, M
Talarico, L
[J]. GASTROENTEROLOGY, 1998, 114 (04) : A1064 - A1064
[3] Risk of ulcerative colitis (UC) and Crohn's disease in offspring of inflammatory bowel disease (IBD) parents: a multicenter Italian study (ig-IBD)
Bortoli, A
Ravelli, P
Paoluzi, P
Snider, L
Bertinelli, E
Peralta, S
Corbellini, A
Colombo, E
Lecis, P
Bennato, R
D'Inca, R
[J]. GASTROENTEROLOGY, 2005, 128 (04) : A317 - A317
[4] Genotypic Overlap Between Crohn's Disease (CD) and Ulcerative Colitis (UC) in a Large Cohort of Patients With Inflammatory Bowel Disease (IBD)
Waterman, Matti
Stempak, Joanne M.
Kabakchiev, Boyko
Xu, Wei
Griffiths, Anne M.
Greenberg, Gordon R.
Steinhart, Hillary
Silverberg, Mark S.
[J]. GASTROENTEROLOGY, 2010, 138 (05) : S678 - S678
[5] Long-term efficacy of azathioprine (AZA) in Crohns disease (CD) beyond 4 years - a European multicenter study in 818 patients
Holtmann, MH
Krummenauer, F
Class, C
Kremeyer, K
Lorenz, D
Rainer, O
Vogel, I
Luegering, N
Gerken, G
Kruis, W
Boehm, S
Schroeder, O
Boecker, U
Reinshagen, M
Schmidt, J
Herfarth, H
Stallmach, A
Duchmann, R
Buening, C
Sturm, A
Galle, PR
Rutgeerts, P
Hommes, DW
DHaens, G
Neurath, M
[J]. GASTROENTEROLOGY, 2004, 126 (04) : A626 - A626
[6] Evidence for genetic heterogeneity in inflammatory bowel disease (IBD); HLA genes in the predisposition to suffer from ulcerative colitis (UC) and Crohn's disease (CD)
Bouma, G
Pool, MO
Crusius, JBA
Schreuder, GMT
Hellemans, HPR
Meijer, BUGA
Kostense, PJ
Giphart, MJ
Meuwissen, SGM
Pena, AS
[J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1997, 109 (01): : 175 - 179
[7] Clinical performance of 2 serological antibody panels for the diagnosis of inflammatory bowel disease (IBD) and the differentiation of Crohn's disease (CD) from ulcerative colitis (UC)
Marcelletti, J
Oh, E
Simpson, L
Smith, K
Wang, SB
Carroll, S
Neri, B
[J]. GASTROENTEROLOGY, 2005, 128 (04) : A1 - A1
[8] Short and Long-Term Effectiveness of Azathioprine and Mercaptopurine in Patients With Inflammatory Bowel Disease (IBD)
Castano-Milla, Carlos
Chaparro, Maria
Mate, J.
Gisben, Javier P.
[J]. GASTROENTEROLOGY, 2011, 140 (05) : S592 - S592
[9] Compared azathioprine efficacy in ulcerative colitis and in Crohn's disease
Kull, E
Beau, P
[J]. GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2002, 26 (04): : 367 - 371
[10] ECCO 2023: New Long-term Data presented on the Efficacy of Ustekinumab in Ulcerative colitis and the Safety Profile of Ustekinumab in Crohn's Disease (CD) and Ulcerative colitis (UC)
不详
[J]. VISCERAL MEDICINE, 2023, 39 (3-4) : 98 - 98

← 1 2 3 4 5 →